Table 1.
Basic characteristics of patients involved in our study.
| Control | Stable | BPAR | |
|---|---|---|---|
| n | 10 | 10 | 10 |
| Age (years; mean ±SD) | 42.50±3.89 | 32.70±3.30 | 36.40±3.59 |
| Gender (Male/Female) | 5/5 | 8/2 | 9/1 |
| Transplant duration (months; range) | – | 1.5 (0.8–3.2) | 0.8 (0.1–3.6) |
| Primary/secondary kidney transplant | – | 10/0 | 10/0 |
| Donor source | |||
| Living-related | – | 2 | 1 |
| Cadaveric | – | 8 | 9 |
| Immunosuppressive regimen | |||
| Prednisone + MMF + CsA | – | 5 | 5 |
| Prednisone + MMF + Tac | – | 5 | 5 |
| Biochemical parameters | |||
| Serum creatinine (μmol/L; mean ±SD) | 74.81±2.98 | 85.35±4.17 | 369.90±125.1# |
| BUN (mmol/L; mean ±SD) | 4.54±0.34 | 5.70±0.44 | 16.85±2.14* |
#
P<0.01 vs. stable group;
*
P<0.001 vs. stable group.
BPAR – biopsy-proven acute rejection; MMF – mycophenolate mofetil; CsA – cyclosporine A; Tac – tacrolimus; BUN – blood urea nitrogen; SD – standard deviation; NS – no significance.